JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2002; 40:1383-1388
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shyu, K.-G. i
Right arrow Articles by Kuan, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shyu, K.-G. i
Right arrow Articles by Kuan, P.

Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure

Kou-G. i Shyu, MD, PhD, FACC*,*, Jun-Jack Cheng, MD, PhD* and Peiliang Kuan, MD, FACC*

* Division of Cardiology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan



View larger version (33K):

[in a new window]
  		Figure 1 Changes in serum creatinine concentration before and after injection of contrast agent in the acetylcysteine and control groups.

 


View larger version (17K):

[in a new window]
  		Figure 2 Comparison of the incidence of an acute reduction in renal function in serum creatinine concentration between 2 and 3 mg/dl and >3 mg/dl in the acetylcysteine (open bars) and control groups (cross-hatched bars).

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.